{
    "2018-10-15": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Companies Growing Their Book Value",
                "features": {
                    "keywords": [
                        "Companies",
                        "Growing",
                        "Book Value"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "PFE or NVO: Which Is the Better Value Stock Right Now?",
                "features": {
                    "keywords": [
                        "PFE",
                        "NVO",
                        "Value Stock"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "AstraZeneca",
                        "hires",
                        "revive",
                        "struggling",
                        "biopharma"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novo Nordisk could close biopharma acquisition this year - CEO",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "biopharma",
                        "acquisition",
                        "CEO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}